
1001 - 5000 employees
Founded 2003
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.
🕒 November 5
🌐 United States, United Kingdom – Remote
💵 $212k - $318k / year
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
👻 Ghost score 10%
Where this job comes from
Posted on Jazz Pharmaceuticals's careers page ↗, not through a job board
First seen by Remote Rocketship November 5
Still open on Jazz Pharmaceuticals's site. Checked 3 hours ago.

1001 - 5000 employees
Founded 2003
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.
• Define and execute global and US payer evidence strategies in Oncology • Lead global HEOR activities and strategies in gastroesophageal adenocarcinoma • Serve as lead HEOR partner for an Oncology asset’s expanding clinical pipeline • Embed payer, HTA, and reimbursement requirements into Phase 2 and Phase 3 development programs • Serve as designated US HEOR lead for commercial, Medicare, and Medicaid access • Execute and author AMCP dossiers, US budget impact models, and state Medicaid submission packages • Partner with US Payer Field Teams on customer-facing economic models, slide decks, and digital tools • Monitor US health policy and prepare evidence roadmaps for ICER reviews and NCCN Evidence Blocks • Evaluate innovative payment models and value-based agreements • Collaborate with Clinical Development, Biostatistics, and Clinical Operations on trial protocols • Integrate PROs, HRQoL, and HCRU measures into pivotal trials • Design rare-disease evidence strategies addressing small samples, heterogeneous presentations, single-arm studies, and surrogate endpoints • Formulate and execute health economic modeling strategies across the product lifecycle • Direct development and validation of adaptable global core economic models • Lead global evidence assets including Global Value Dossiers, systematic literature reviews, and evidence libraries • Co-deliver HTA evidence packages with EU/INT HEOR teams, including ITCs, NMAs, and economic model adaptations • Design and deliver real-world evidence, natural history, burden-of-illness, treatment-pattern, and comparative-effectiveness studies • Lead HEOR launch-readiness workstreams and lifecycle-management evidence strategies • Support sBLA/sNDA submissions and label expansions • Collaborate on post-marketing evidence programs and value-defense activities • Govern HEOR commitments in Integrated Evidence Generation Plans • Partner with Market Access, Brand Teams, Medical Affairs, Regulatory, and Commercial teams • Lead publication strategy and present findings at scientific and health-economic congresses • Mentor junior scientists, cross-functional colleagues, and HEOR fellows • Ensure compliance with legal, regulatory, and corporate standards
• Master’s degree (MSc, MS, MPH, PhD) in Health Economics, Outcomes Research, Pharmacoeconomics, or a closely related quantitative field • Minimum of 7–10 years of experience in HEOR, Global Value, or Health Economics within the biopharmaceutical industry or a top-tier HEOR consulting firm • Experience with oncology assets preferred • Demonstrated track record leading HEOR strategy and executing evidence deliverables for marketed, inline pharmaceutical products • Deep understanding of US payer and population health decision makers, including Oncology Pathways • Experience managing regional trade-offs on evidence needs as part of Phase 2/3 protocol development • Launch lead for at least 2 assets as US HEOR lead, or country-level HTA lead • Proven track record as US HEOR lead or driving US pre-launch HEOR deliverables, including AMCP PIE dossiers, US budget impact models, and payer field enablement • Experience conducting post-marketing RWE, patient registry studies, and economic evaluations in rare diseases, specialized medicine, or complex chronic conditions • Substantial experience collaborating with regional HEOR teams to deliver evidence packages supporting global HTA re-assessments, renewals, or pricing renegotiations • Strong peer-reviewed publication record in health economics and outcomes research • Deep working knowledge of US managed care archetypes and major international HTA systems • Advanced expertise in health economic modeling, including Markov state-transition models, partitioned survival models, microsimulation, and discrete event simulation • Demonstrated experience partnering with US Payer Field Teams to develop interactive economic models and value presentation tools • Practical understanding of rare disease evidence generation challenges • Experience influencing Phase 2/3 study designs, comparator selection, and integration of HEOR/PRO endpoints • Strong understanding of US health policy developments and value assessment bodies • Proven ability to execute complex deliverables including AMCP dossiers, GVDs, NMAs, economic models, and RWE protocols • Ability to lead cross-functionally and mentor junior researchers • Experience managing multi-million-dollar research budgets, vendor selection, external CROs, and academic partners
• Discretionary annual cash bonus or incentive compensation • Discretionary equity grants • Medical insurance • Dental insurance • Vision insurance • 401k retirement savings plan • Flexible paid vacation
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🕒 November 5
Product delivery director guiding Employee Benefits technology capabilities at Voya, a financial services company. Shaping roadmaps, prioritization, readiness, testing, and adoption.
🕒 November 5
Senior sales leader managing commercial account executives, renewals, and expansion for Precisely’s data quality and location intelligence software. Driving forecasts, retention, pipeline, and AI-enabled sales productivity.
🇺🇸 United States – Remote
💰 Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🕒 November 4
WelbeHealth IT director leading enterprise technology portfolios, governance, and delivery. Aligning investments, budgets, and delivery practices to improve care for vulnerable seniors.
🇺🇸 United States – Remote
💵 $159.9k - $211.1k / year
💰 $30M Series C on 2020-02
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🕒 November 4
RCM director launching Practice by Numbers’ dental revenue cycle business. Building US and India teams, workflows, client services and revenue growth operations.
🕒 November 4
Director leading client partnerships and revenue cycle operations for Ensemble’s healthcare-system clients. Driving performance, reporting, compliance updates, and strategic service-line development.